Overview
Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome, sometimes referred to by the abbreviation GDVCAT or by its Orphanet code 480898, is a very rare genetic brain disorder that affects how the nervous system develops and works. The condition is caused by changes (mutations) in a specific gene that disrupt normal brain development, particularly in an area at the back of the brain called the cerebellum, which controls balance and coordination. Over time, the cerebellum gradually shrinks, a process called cerebellar atrophy. Children with this syndrome typically show signs early in life, including weak muscle tone in the trunk (truncal hypotonia), delays in reaching developmental milestones like sitting, walking, and talking, and problems with vision. The visual problems can include unusual eye movements or structural changes in the eyes. Because the cerebellum continues to deteriorate over time, symptoms often get worse as the child grows. There is currently no cure for this condition. Treatment focuses on managing symptoms and supporting development through physical therapy, occupational therapy, speech therapy, and regular monitoring by a team of specialists. Early intervention is important to help children reach their best possible potential.
Key symptoms:
Global developmental delay (slow progress in motor, speech, and thinking skills)Low muscle tone in the trunk (truncal hypotonia), making it hard to sit or stand uprightProgressive shrinkage of the cerebellum (cerebellar atrophy) seen on brain scansVision problems or unusual eye movementsPoor coordination and balanceDelayed or absent walkingSpeech and language delaysIntellectual disabilityAbnormal eye structure or functionUnsteady or wobbly movements (ataxia)
Clinical phenotype terms (31)— hover any for plain English
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome.
Community
No community posts yet. Be the first to share your experience with Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome.
Start the conversation →Latest news about Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome
No recent news articles for Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Which specific gene mutation has been found in my child, and what does it mean for their prognosis?,How often should we repeat brain MRI scans to monitor cerebellar atrophy?,What therapies are most important to start right away, and how often should they happen?,Are there any clinical trials or research studies we should consider enrolling in?,What signs should prompt us to go to the emergency room?,How can we best support my child's learning and communication at school?,Should other family members be tested for this genetic change?
Common questions about Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome
What is Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome?
Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome, sometimes referred to by the abbreviation GDVCAT or by its Orphanet code 480898, is a very rare genetic brain disorder that affects how the nervous system develops and works. The condition is caused by changes (mutations) in a specific gene that disrupt normal brain development, particularly in an area at the back of the brain called the cerebellum, which controls balance and coordination. Over time, the cerebellum gradually shrinks, a process called cerebellar atrophy. Children with this sy
How is Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome inherited?
Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome typically begin?
Typical onset of Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome is infantile. Age of onset can vary across affected individuals.